These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 12823147

  • 21. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease.
    Mantzaris GJ, Christidou A, Sfakianakis M, Roussos A, Koilakou S, Petraki K, Polyzou P.
    Inflamm Bowel Dis; 2009 Mar; 15(3):375-82. PubMed ID: 19009634
    [Abstract] [Full Text] [Related]

  • 22. Natalizumab for induction of remission in Crohn's disease.
    Macdonald JK, McDonald JW.
    Cochrane Database Syst Rev; 2006 Jul 19; (3):CD006097. PubMed ID: 16856112
    [Abstract] [Full Text] [Related]

  • 23. On the limitation of 6-tioguaninenucleotide monitoring during tioguanine treatment.
    de Boer NK, de Graaf P, Wilhelm AJ, Mulder CJ, van Bodegraven AA.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):447-51. PubMed ID: 16128683
    [Abstract] [Full Text] [Related]

  • 24. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D, Macdonald JK, Chande N.
    Cochrane Database Syst Rev; 2014 Feb 21; (2):CD010410. PubMed ID: 24558033
    [Abstract] [Full Text] [Related]

  • 25. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA.
    Aliment Pharmacol Ther; 2004 Oct 21; 20 Suppl 4():102-5. PubMed ID: 15352904
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy.
    Musumba CO.
    Aliment Pharmacol Ther; 2013 Nov 21; 38(9):1025-37. PubMed ID: 24099468
    [Abstract] [Full Text] [Related]

  • 29. Is there a role for thioguanine therapy in IBD in 2017 and beyond?
    Taylor KM, Ward MG, Blaker PA, Sparrow MP.
    Expert Rev Gastroenterol Hepatol; 2017 May 21; 11(5):473-486. PubMed ID: 28276819
    [Abstract] [Full Text] [Related]

  • 30. Drug interaction between infliximab and azathioprine in patients with Crohn's disease.
    Roblin X, Serre-Debeauvais F, Phelip JM, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2003 Nov 01; 18(9):917-25. PubMed ID: 14616155
    [Abstract] [Full Text] [Related]

  • 31. Tioguanine in the treatment of refractory coeliac disease--a single centre experience.
    Tack GJ, van Asseldonk DP, van Wanrooij RL, van Bodegraven AA, Mulder CJ.
    Aliment Pharmacol Ther; 2012 Aug 01; 36(3):274-81. PubMed ID: 22646133
    [Abstract] [Full Text] [Related]

  • 32. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E, Macdonald JK, Sutherland LR.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD000545. PubMed ID: 19821270
    [Abstract] [Full Text] [Related]

  • 33. Thiopurines in inflammatory bowel disease revisited.
    Bär F, Sina C, Fellermann K.
    World J Gastroenterol; 2013 Mar 21; 19(11):1699-706. PubMed ID: 23555158
    [Abstract] [Full Text] [Related]

  • 34. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
    Chebli JM, Gaburri PD, De Souza AF, Pinto AL, Chebli LA, Felga GE, Forn CG, Pimentel CF.
    J Gastroenterol Hepatol; 2007 Feb 21; 22(2):268-74. PubMed ID: 17295882
    [Abstract] [Full Text] [Related]

  • 35. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
    Miehsler W, Reinisch W, Moser G, Gangl A, Vogelsang H.
    Am J Gastroenterol; 2001 Mar 21; 96(3):782-7. PubMed ID: 11280551
    [Abstract] [Full Text] [Related]

  • 36. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF.
    Am J Gastroenterol; 1998 Oct 21; 93(10):1860-6. PubMed ID: 9772045
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Prefontaine E, Sutherland LR, Macdonald JK, Cepoiu M.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD000067. PubMed ID: 19160175
    [Abstract] [Full Text] [Related]

  • 40. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec 21; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.